左侧乳腺癌患者接受中度深吸气屏气与自由呼吸治疗的比较研究

IF 2.1 Q3 ONCOLOGY
Anupam Muraleedharan, Sandip Kumar Barik, Deepak Kumar Das, Saroj Kumar Das Majumdar, Bikash Ranjan Mahapatra, Bijay Kumar Barik, Mathan Kumar Ramasubbu, Nehla Haroon K. M., Poornima Devi U., Sk Soel Ahmed, Priyanka Mukherjee, Ashutosh Pattanaik, Avinash Badajena, Minakshi Mishra, Satyabrata Kanungo, Sovan Sarang Dhar, Dillip Kumar Parida
{"title":"左侧乳腺癌患者接受中度深吸气屏气与自由呼吸治疗的比较研究","authors":"Anupam Muraleedharan, Sandip Kumar Barik, Deepak Kumar Das, Saroj Kumar Das Majumdar, Bikash Ranjan Mahapatra, Bijay Kumar Barik, Mathan Kumar Ramasubbu, Nehla Haroon K. M., Poornima Devi U., Sk Soel Ahmed, Priyanka Mukherjee, Ashutosh Pattanaik, Avinash Badajena, Minakshi Mishra, Satyabrata Kanungo, Sovan Sarang Dhar, Dillip Kumar Parida","doi":"10.1186/s43046-024-00214-6","DOIUrl":null,"url":null,"abstract":"The moderate deep inspiratory breath hold (mDIBH) is a modality famed for cardiac sparing. Prospective studies based on this are few from the eastern part of the world and India. We intend to compare the dosimetry between mDIBH and free-breathing (FB) plans. Thirty-two locally advanced left breast cancer patients were taken up for the study. All patients received a dose of 50 Gy in 25 fractions to the chest wall/intact breast, followed by a 10-Gy boost to the lumpectomy cavity in the case of breast conservation surgery. All the patients were treated in mDIBH using active breath coordinator (ABC). The data from the two dose volume histograms were compared regarding plan quality and the doses received by the organs at risk. Paired t-test was used for data analysis. The dose received by the heart in terms of V5, V10, and V30 (4.55% vs 8.39%) and mean dose (4.73 Gy vs 6.74 Gy) were statistically significant in the ABC group than that in the FB group (all p-values < 0.001). Also, the dose received by the LADA in terms of V30 (19.32% vs 24.87%) and mean dose (32.99 Gy vs 46.65 Gy) were significantly less in the ABC group. The mean treatment time for the ABC group was 20 min, while that for the free-breathing group was 10 min. Incorporating ABC-mDIBH for left-sided breast cancer radiotherapy significantly reduces the doses received by the heart, LADA, and left and right lung, with no compromise in plan quality but with an increase in treatment time.","PeriodicalId":17301,"journal":{"name":"Journal of the Egyptian National Cancer Institute","volume":"89 1","pages":""},"PeriodicalIF":2.1000,"publicationDate":"2024-04-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"A comparative study in left-sided breast cancer treated with moderate deep inspiratory breath hold versus free breathing\",\"authors\":\"Anupam Muraleedharan, Sandip Kumar Barik, Deepak Kumar Das, Saroj Kumar Das Majumdar, Bikash Ranjan Mahapatra, Bijay Kumar Barik, Mathan Kumar Ramasubbu, Nehla Haroon K. M., Poornima Devi U., Sk Soel Ahmed, Priyanka Mukherjee, Ashutosh Pattanaik, Avinash Badajena, Minakshi Mishra, Satyabrata Kanungo, Sovan Sarang Dhar, Dillip Kumar Parida\",\"doi\":\"10.1186/s43046-024-00214-6\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"The moderate deep inspiratory breath hold (mDIBH) is a modality famed for cardiac sparing. Prospective studies based on this are few from the eastern part of the world and India. We intend to compare the dosimetry between mDIBH and free-breathing (FB) plans. Thirty-two locally advanced left breast cancer patients were taken up for the study. All patients received a dose of 50 Gy in 25 fractions to the chest wall/intact breast, followed by a 10-Gy boost to the lumpectomy cavity in the case of breast conservation surgery. All the patients were treated in mDIBH using active breath coordinator (ABC). The data from the two dose volume histograms were compared regarding plan quality and the doses received by the organs at risk. Paired t-test was used for data analysis. The dose received by the heart in terms of V5, V10, and V30 (4.55% vs 8.39%) and mean dose (4.73 Gy vs 6.74 Gy) were statistically significant in the ABC group than that in the FB group (all p-values < 0.001). Also, the dose received by the LADA in terms of V30 (19.32% vs 24.87%) and mean dose (32.99 Gy vs 46.65 Gy) were significantly less in the ABC group. The mean treatment time for the ABC group was 20 min, while that for the free-breathing group was 10 min. Incorporating ABC-mDIBH for left-sided breast cancer radiotherapy significantly reduces the doses received by the heart, LADA, and left and right lung, with no compromise in plan quality but with an increase in treatment time.\",\"PeriodicalId\":17301,\"journal\":{\"name\":\"Journal of the Egyptian National Cancer Institute\",\"volume\":\"89 1\",\"pages\":\"\"},\"PeriodicalIF\":2.1000,\"publicationDate\":\"2024-04-08\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of the Egyptian National Cancer Institute\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1186/s43046-024-00214-6\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of the Egyptian National Cancer Institute","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1186/s43046-024-00214-6","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

中度深吸气屏气(mDIBH)是一种著名的心脏疏通方式。在世界东部和印度,基于这种方式的前瞻性研究很少。我们打算比较 mDIBH 和自由呼吸(FB)计划之间的剂量测定。研究对象为 32 名局部晚期左侧乳腺癌患者。所有患者的胸壁/完好乳房都接受了 50 Gy 剂量(25 次分次)的治疗,如果进行了保乳手术,则在肿块切除腔内进行 10 Gy 的增量治疗。所有患者均采用主动呼吸协调器(ABC)进行 mDIBH 治疗。对两种剂量体积直方图的数据进行了比较,以了解计划质量和危险器官所接受的剂量。数据分析采用配对 t 检验。在心脏接受的剂量(V5、V10 和 V30)(4.55% vs 8.39%)和平均剂量(4.73 Gy vs 6.74 Gy)方面,ABC 组比 FB 组有显著的统计学差异(所有 p 值均小于 0.001)。此外,就 V30(19.32% vs 24.87%)和平均剂量(32.99 Gy vs 46.65 Gy)而言,ABC 组的 LADA 接受的剂量也明显低于 FB 组(P 值均小于 0.001)。ABC 组的平均治疗时间为 20 分钟,而自由呼吸组为 10 分钟。在左侧乳腺癌放疗中采用 ABC-mDIBH 技术可大大减少心脏、左侧乳腺组织、左肺和右肺所接受的剂量,同时不会影响计划质量,但会增加治疗时间。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
A comparative study in left-sided breast cancer treated with moderate deep inspiratory breath hold versus free breathing
The moderate deep inspiratory breath hold (mDIBH) is a modality famed for cardiac sparing. Prospective studies based on this are few from the eastern part of the world and India. We intend to compare the dosimetry between mDIBH and free-breathing (FB) plans. Thirty-two locally advanced left breast cancer patients were taken up for the study. All patients received a dose of 50 Gy in 25 fractions to the chest wall/intact breast, followed by a 10-Gy boost to the lumpectomy cavity in the case of breast conservation surgery. All the patients were treated in mDIBH using active breath coordinator (ABC). The data from the two dose volume histograms were compared regarding plan quality and the doses received by the organs at risk. Paired t-test was used for data analysis. The dose received by the heart in terms of V5, V10, and V30 (4.55% vs 8.39%) and mean dose (4.73 Gy vs 6.74 Gy) were statistically significant in the ABC group than that in the FB group (all p-values < 0.001). Also, the dose received by the LADA in terms of V30 (19.32% vs 24.87%) and mean dose (32.99 Gy vs 46.65 Gy) were significantly less in the ABC group. The mean treatment time for the ABC group was 20 min, while that for the free-breathing group was 10 min. Incorporating ABC-mDIBH for left-sided breast cancer radiotherapy significantly reduces the doses received by the heart, LADA, and left and right lung, with no compromise in plan quality but with an increase in treatment time.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
3.50
自引率
0.00%
发文量
46
审稿时长
11 weeks
期刊介绍: As the official publication of the National Cancer Institute, Cairo University, the Journal of the Egyptian National Cancer Institute (JENCI) is an open access peer-reviewed journal that publishes on the latest innovations in oncology and thereby, providing academics and clinicians a leading research platform. JENCI welcomes submissions pertaining to all fields of basic, applied and clinical cancer research. Main topics of interest include: local and systemic anticancer therapy (with specific interest on applied cancer research from developing countries); experimental oncology; early cancer detection; randomized trials (including negatives ones); and key emerging fields of personalized medicine, such as molecular pathology, bioinformatics, and biotechnologies.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信